AstraZeneca Vaccine Linked to Rare Blood Clots, European Union Confirms

HNGN

Published

European regulators concluded a strong association between AstraZeneca’s COVID-19 vaccine and life-threatening conditions involving the uncommon combination of low levels of blood platelets and blood clots.

Full Article